Rho/Rho-associated kinase pathway in glaucoma (Review)
- Authors:
- Jing Wang
- Xiaohong Liu
- Yisheng Zhong
-
Affiliations: Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai 200025, P.R. China - Published online on: September 16, 2013 https://doi.org/10.3892/ijo.2013.2100
- Pages: 1357-1367
This article is mentioned in:
Abstract
Weinreb RN and Khaw PT: Primary open-angle glaucoma. Lancet. 363:1711–1720. 2004. View Article : Google Scholar : PubMed/NCBI | |
Quigley HA: Glaucoma. Lancet. 377:1367–1377. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sommer A: Intraocular pressure and glaucoma. Am J Ophthalmol. 107:186–188. 1989. View Article : Google Scholar | |
Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA and Javitt J: Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 266:369–374. 1991. View Article : Google Scholar : PubMed/NCBI | |
Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J and Menage MJ: Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 99:1499–1504. 1992. View Article : Google Scholar : PubMed/NCBI | |
Mitchell P, Smith W, Attebo K and Healey PR: Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology. 103:1661–1669. 1996. View Article : Google Scholar : PubMed/NCBI | |
Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 126:487–497. 1998. View Article : Google Scholar | |
Collaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 126:498–505. 1998. View Article : Google Scholar : PubMed/NCBI | |
The AGIS Investigators: The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 130:429–440. 2000. View Article : Google Scholar | |
Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA and Mills RP: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 108:1943–1953. 2001. View Article : Google Scholar | |
Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson MR and Kass MA: The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 120:714–720. 2002. View Article : Google Scholar : PubMed/NCBI | |
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR and Gordon MO: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 120:701–713. 2002. View Article : Google Scholar | |
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L and Komaroff E: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 121:48–56. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hernandez MR: The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res. 19:297–321. 2000. View Article : Google Scholar : PubMed/NCBI | |
Burgoyne CF: A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res. 93:120–132. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lutjen-Drecoll E: Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res. 18:91–119. 1999. View Article : Google Scholar : PubMed/NCBI | |
Tan JC, Peters DM and Kaufman PL: Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol. 17:168–174. 2006.PubMed/NCBI | |
Gabelt BT and Kaufman PL: Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 24:612–637. 2005. View Article : Google Scholar : PubMed/NCBI | |
Grant WM: Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 69:783–801. 1963. View Article : Google Scholar : PubMed/NCBI | |
Johnson M: What controls aqueous humour outflow resistance? Exp Eye Res. 82:545–557. 2006. View Article : Google Scholar : PubMed/NCBI | |
Tamm ER: The trabecular meshwork outflow pathways: Structural and functional aspects. Exp Eye Res. 88:648–655. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kumar J and Epstein DL: Rho GTPase-mediated cytoskeletal organization in Schlemm’s canal cells play a critical role in the regulation of aqueous humor outflow facility. J Cell Biochem. 112:600–606. 2011.PubMed/NCBI | |
Ethier CR: The inner wall of Schlemm’s canal. Exp Eye Res. 74:161–172. 2002. | |
Wiederholt M, Thieme H and Stumpff F: The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res. 19:271–295. 2000. View Article : Google Scholar : PubMed/NCBI | |
Lutjen-Drecoll E: Morphological changes in glaucomatous eyes and the role of TGF β2 for the pathogenesis of the disease. Exp Eye Res. 81:1–4. 2005. | |
Fuchshofer R and Tamm ER: The role of TGF-β in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 347:279–290. 2012. | |
Bradley JM, Vranka J, Colvis CM, Conger DM, Alexander JP, Fisk AS, Samples JR and Acott TS: Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 39:2649–2658. 1998.PubMed/NCBI | |
Tian B, Geiger B, Epstein DL and Kaufman PL: Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 41:619–623. 2000.PubMed/NCBI | |
Tian B, Gabelt BT, Geiger B and Kaufman PL: The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res. 88:713–717. 2009. View Article : Google Scholar : PubMed/NCBI | |
Last JA, Pan T, Ding Y, Reilly CM, Keller K, Acott TS, Fautsch MP, Murphy CJ and Russell P: Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci. 52:2147–2152. 2011. View Article : Google Scholar : PubMed/NCBI | |
Erschbamer MK, Hofstetter CP and Olson L: RhoA, RhoB, RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord, sensory ganglia, and corticospinal tract neurons and long-lasting specific changes following spinal cord injury. J Comp Neurol. 484:224–233. 2005. View Article : Google Scholar : PubMed/NCBI | |
Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar | |
Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K and Narumiya S: ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 392:189–193. 1996. View Article : Google Scholar : PubMed/NCBI | |
Riento K and Ridley AJ: Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 4:446–456. 2003. View Article : Google Scholar : PubMed/NCBI | |
Leung T, Chen XQ, Manser E and Lim L: The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol. 16:5313–5327. 1996.PubMed/NCBI | |
Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A and Olson MF: Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 3:339–345. 2001. View Article : Google Scholar : PubMed/NCBI | |
Sebbagh M, Renvoizé C, Hamelin J, Riché N, Bertoglio J and Bréard J: Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol. 3:346–352. 2001. View Article : Google Scholar : PubMed/NCBI | |
Sebbagh M, Hamelin J, Bertoglio J, Solary E and Bréard J: Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med. 201:465–471. 2005. View Article : Google Scholar : PubMed/NCBI | |
Van Aelst L and D’Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev. 11:2295–2322. 1997.PubMed/NCBI | |
Ridley AJ, Paterson HF, Johnston CL, Diekmann D and Hall A: The small GTP-binding protein rho regulates growth factor-induced membrane ruffling. Cell. 70:401–410. 1992. View Article : Google Scholar : PubMed/NCBI | |
Ridley AJ and Hall A: Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J. 13:2600–2610. 1994.PubMed/NCBI | |
Nobes C and Hall A: Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev. 4:77–81. 1994. View Article : Google Scholar : PubMed/NCBI | |
Takai Y, Sasaki T, Tanaka K and Nakanishi H: Rho as a regulator of the cytoskeleton. Trends Biochem Sci. 20:227–231. 1995. View Article : Google Scholar : PubMed/NCBI | |
Paterson HF, Self AJ, Garrett MD, Just I, Aktories K and Hall A: Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol. 111:1001–1007. 1990. View Article : Google Scholar : PubMed/NCBI | |
Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K and Takai Y: Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem. 267:8719–8722. 1992.PubMed/NCBI | |
Narumiya S: The small GTPase Rho: cellular functions and signal transduction. J Biochem (Tokyo). 120:215–228. 1996. View Article : Google Scholar : PubMed/NCBI | |
Gong MC, Iizuka K, Nixon G, Browne JP, Hall A, Eccleston JF, Sugai M, Kobayashi S, Somlyo AV and Somlyo AP: Role of guanine nucleotide-binding proteins - ras-family or trimeric proteins or both - in Ca2+ sensitization of smooth muscle. Proc Natl Acad Sci USA. 93:1340–1345. 1996. View Article : Google Scholar : PubMed/NCBI | |
Narumiya S, Ishizaki T and Watanabe N: Rho effectors and reorganization of actin cytoskeleton. FEBS Lett. 410:68–72. 1997. View Article : Google Scholar : PubMed/NCBI | |
Kaibuchi K, Kuroda S and Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem. 68:459–486. 1999. View Article : Google Scholar : PubMed/NCBI | |
Somlyo AP and Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 522:177–185. 2000. View Article : Google Scholar : PubMed/NCBI | |
Fukata Y, Amano M and Kaibuchi K: Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 22:32–39. 2001. View Article : Google Scholar : PubMed/NCBI | |
Nakayama M, Amano M, Katsumi A, Kaneko T, Kawabata S, Takefuji M and Kaibuchi K: Rho-kinase and myosin II activities are required for cell type and environment specific migration. Genes Cells. 10:107–117. 2005. View Article : Google Scholar : PubMed/NCBI | |
Nakajima E, Nakajima T, Minagawa Y, Shearer TR and Azuma M: Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes. J Pharm Sci. 94:701–708. 2005. View Article : Google Scholar : PubMed/NCBI | |
Amano M, Nakayama M and Kaibuchi K: Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken). 67:545–554. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tan HB, Zhong YS, Cheng Y and Shen X: Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage. Int J Ophthalmol. 4:652–657. 2011.PubMed/NCBI | |
Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M and Hidaka H: Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther. 241:1033–1040. 1987.PubMed/NCBI | |
Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, Suzuki Y and Hidaka H: Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol. 98:1091–1100. 1989. View Article : Google Scholar : PubMed/NCBI | |
Honjo M, Inatani M, Kido N, Sawamura T, Yue BY, Honda Y and Tanihara H: A myosin light chain kinase inhibitor, ML-9, lowers the intraocular pressure in rabbit eyes. Exp Eye Res. 75:135–142. 2002. View Article : Google Scholar : PubMed/NCBI | |
Yoneda A, Multhaupt HA and Couchman JR: The Rho kinases I and II regulate different aspects of myosin II activity. J Cell Biol. 170:443–453. 2005. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X and Surks HK: ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res. 104:531–540. 2009. View Article : Google Scholar : PubMed/NCBI | |
Hartshorne DJ: Myosin phosphatase: subunits and interactions. Acta Physiol Scand. 164:483–493. 1998. View Article : Google Scholar : PubMed/NCBI | |
Pfitzer G: Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol. 91:497–503. 2001.PubMed/NCBI | |
Harnett KM and Biancani P: Calcium-dependent and calcium-independent contractions in smooth muscles. Am J Med. 115(Suppl 3A): 24S–30S. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A and Kaibuchi K: Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science. 273:245–248. 1996. View Article : Google Scholar : PubMed/NCBI | |
Wettschureck N and Offermanns S: Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med. 80:629–638. 2002. View Article : Google Scholar : PubMed/NCBI | |
Somlyo AP and Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 83:1325–1358. 2003. | |
Hall A: Rho GTPases and the actin cytoskeleton. Science. 279:509–514. 1998. View Article : Google Scholar | |
Ridley AJ: Rho GTPases and cell migration. J Cell Sci. 114:2713–2722. 2001.PubMed/NCBI | |
Jaffe AB and Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol. 21:247–269. 2005. View Article : Google Scholar : PubMed/NCBI | |
Spindler V, Schlegel N and Waschke J: Role of GTPases in control of microvascular permeability. Cardiovasc Res. 87:243–253. 2010. View Article : Google Scholar : PubMed/NCBI | |
Thieme H, Nuskovski M, Nass JU, Pleyer U, Strauss O and Wiederholt M: Mediation of calcium-independent contraction in trabecular meshwork through protein kinase c and rho-A. Invest Ophthalmol Vis Sci. 41:4240–4246. 2000.PubMed/NCBI | |
Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY, Narumiya S and Honda Y: Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 42:137–144. 2001.PubMed/NCBI | |
Rao PV, Deng PF, Kumar J and Epstein DL: Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 42:1029–1037. 2001.PubMed/NCBI | |
Goldhagen B, Proia AD, Epstein DL and Rao PV: Elevated levels of RhoA in the optic nerve head of human eyes with glaucoma. J Glaucoma. 21:530–538. 2012. View Article : Google Scholar : PubMed/NCBI | |
Epstein DL, Rowlette LL and Roberts BC: Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 40:74–81. 1999.PubMed/NCBI | |
Rao PV, Deng P, Sasaki Y and Epstein DL: Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res. 80:197–206. 2005. View Article : Google Scholar : PubMed/NCBI | |
Geiger B, Yehuda-Levenberg S and Bershadsky AD: Molecular interactions in the submembrane plaque of cell-cell and cell-matrix adhesions. Acta Anat (Basel). 154:46–62. 1995. View Article : Google Scholar : PubMed/NCBI | |
Rosenthal R, Choritz L, Schlott S, Bechrakis NE, Jaroszewski J, Wiederholt M and Thieme H: Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork. Exp Eye Res. 80:837–845. 2005. View Article : Google Scholar : PubMed/NCBI | |
Renieri G, Choritz L, Rosenthal R, Meissner S, Pfeiffer N and Thieme H: Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork. Graefes Arch Clin Exp Ophthalmol. 246:1107–1115. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lu Z, Overby DR, Scott PA, Freddo TF and Gong H: The mechanism of increasing outflow facility by rho-kinase inhibition with Y-27632 in bovine eyes. Exp Eye Res. 86:271–281. 2008. View Article : Google Scholar : PubMed/NCBI | |
Johnstone MA: The aqueous outflow system as a mechanical pump: evidence from examination of tissue and aqueous movement in human and non-human primates. J Glaucoma. 13:421–438. 2004. View Article : Google Scholar : PubMed/NCBI | |
Rao VP and Epstein DL: Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. BioDrugs. 21:167–177. 2007. View Article : Google Scholar : PubMed/NCBI | |
WuDunn D: Mechanobiology of trabecular meshwork cells. Exp Eye Res. 88:718–723. 2009. View Article : Google Scholar : PubMed/NCBI | |
Wiederholt M, Bielka S, Schweig F, Lutjen-Drecoll E and Lepple-Wienhues A: Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp Eye Res. 61:223–234. 1995. View Article : Google Scholar : PubMed/NCBI | |
Honjo M, Inatani M, Kido N, Sawamura T, Yue BY, Honda Y and Tanihara H: Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch Ophthalmol. 119:1171–1178. 2001. View Article : Google Scholar : PubMed/NCBI | |
Tokushige H, Inatani M, Nemoto S, Sakaki H, Katayama K, Uehata M and Tanihara H: Effects of topical administration of Y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci. 48:3216–3222. 2007. View Article : Google Scholar : PubMed/NCBI | |
Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J and Araie M: Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol. 126:309–315. 2008. View Article : Google Scholar : PubMed/NCBI | |
Fukunaga T, Ikesugi K, Nishio M, Sugimoto M, Sasoh M, Hidaka H and Uji Y: The effect of the Rho-associated protein kinase inhibitor, HA-1077, in the rabbit ocular hypertension model induced by water loading. Curr Eye Res. 34:42–47. 2009. View Article : Google Scholar : PubMed/NCBI | |
Gottanka J, Chan D, Eichhorn M, Lutjen-Drecoll E and Ethier CR: Effects of TGF-β2 in perfused human eyes. Invest Ophthalmol Vis Sci. 45:153–158. 2004. | |
Mettu PS, Deng PF, Misra UK, Gawdi G, Epstein DL and Rao PV: Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 45:2263–2271. 2004. View Article : Google Scholar : PubMed/NCBI | |
Zhang M, Maddala R and Rao PV: Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork. Am J Physiol Cell Physiol. 295:C1057–C1070. 2008. View Article : Google Scholar : PubMed/NCBI | |
Waki M, Yoshida Y, Oka T and Azuma M: Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr Eye Res. 22:470–474. 2001. View Article : Google Scholar : PubMed/NCBI | |
Wiederholt M and Stumpff H: The trabecular meshwork and aqueous humor reabsorption. Curr Top Membr. 45:163–202. 1998. View Article : Google Scholar | |
Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M and Narumiya S: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:990–994. 1997. View Article : Google Scholar : PubMed/NCBI | |
Iizuka K, Yoshii A, Samizo K, Tsukagoshi H, Ishizuka T, Dobashi K, Nakazawa T and Mori M: A major role for the rho-associated coiled coil forming protein kinase in G-protein-mediated Ca2+ sensitization through inhibition of myosin phosphatase in rabbit trachea. Br J Pharmacol. 128:925–933. 1999. View Article : Google Scholar : PubMed/NCBI | |
Lütjen-Drecoll E, Futa R and Rohen JW: Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 21:563–573. 1981.PubMed/NCBI | |
Yue BY: The extracellular matrix and its modulation in the trabecular meshwork. Surv Ophthalmol. 40:379–390. 1996. View Article : Google Scholar : PubMed/NCBI | |
Tamm ER and Fuchshofer R: What increases outflow resistance in primary open-angle glaucoma? Surv Ophthalmol. 52(Suppl 2): S101–S104. 2007. View Article : Google Scholar : PubMed/NCBI | |
Acott TS and Kelley MJ: Extracellular matrix in the trabecular meshwork. Exp Eye Res. 86:543–561. 2008. View Article : Google Scholar : PubMed/NCBI | |
Keller KE, Aga M, Bradley JM, Kelley MJ and Acott TS: Extracellular matrix turnover and outflow resistance. Exp Eye Res. 88:676–682. 2009. View Article : Google Scholar : PubMed/NCBI | |
Pattabiraman PP and Rao PV: Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. Am J Physiol Cell Physiol. 298:C749–763. 2010. View Article : Google Scholar : PubMed/NCBI | |
Nakamura Y, Hirano S, Suzuki K, Seki K, Sagara T and Nishida T: Signaling mechanism of TGF-β1-induced collagen contraction mediated by bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci. 43:3465–3472. 2002. | |
Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH and Clark AF: TGFβ2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 47:226–234. 2006. | |
Iyer P, Maddala R, Pattabiraman PP and Rao PV: Connective tissue growth factor-mediated upregulation of neuromedin U expression in trabecular meshwork cells and its role in homeostasis of aqueous humor outflow. Invest Ophthalmol Vis Sci. 53:4952–4962. 2012. View Article : Google Scholar : PubMed/NCBI | |
Bershadsky AD, Balaban NQ and Geiger B: Adhesion-dependent cell mechanosensitivity. Annu Rev Cell Dev Biol. 19:677–695. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kaunas R, Nguyen P, Usami S and Chien S: Cooperative effects of Rho and mechanical stretch on stress fiber organization. Proc Natl Acad Sci USA. 102:15895–15900. 2005. View Article : Google Scholar : PubMed/NCBI | |
Shikata Y, Rios A, Kawkitinarong K, DePaola N, Garcia JG and Birukov KG: Differential effects of shear stress and cyclic stretch on focal adhesion remodeling, site-specific FAK phosphorylation, and small GTPases in human lung endothelial cells. Exp Cell Res. 304:40–49. 2005. View Article : Google Scholar : PubMed/NCBI | |
Ingber DE: Cellular mechanotransduction: putting all the pieces together again. FASEB J. 20:811–827. 2006. View Article : Google Scholar : PubMed/NCBI | |
Tzima E: Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response. Circ Res. 98:176–185. 2006. View Article : Google Scholar : PubMed/NCBI | |
Schlunck G, Han H, Wecker T, Kampik D, Meyer-ter-Vehn T and Grehn F: Substrate rigidity modulates cell matrix interactions and protein expression in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 49:262–269. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kameda T, Inoue T, Inatani M, Fujimoto T, Honjo M, Kasaoka N, Inoue-Mochita M, Yoshimura N and Tanihara H: The effect of Rho-associated protein kinase inhibitor on monkey Schlemm’s canal endothelial cells. Invest Ophthalmol Vis Sci. 53:3092–3103. 2012.PubMed/NCBI | |
Epstein DL, Freddo TF, Bassett-Chu S, Chung M and Karageuzian L: Influence of ethacrynic acid on outflow facility in the monkey and calf eye. Invest Ophthalmol Vis Sci. 28:2067–2075. 1987.PubMed/NCBI | |
Ethier CR, Read AT and Chan DW: Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes. Invest Ophthalmol Vis Sci. 47:1991–1998. 2006. View Article : Google Scholar : PubMed/NCBI | |
Inoue T, Pattabiraman PP, Epstein DL and Rao PV: Effects of chemical inhibition of N-WASP, a critical regulator of actin polymerization on aqueous humor outflow through the conventional pathway. Exp Eye Res. 90:360–367. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bill A and Svedbergh B: Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm - an attempt to localize the main resistance to outflow of aqueous humor in man. Acta Ophthalmol (Copenh). 50:295–320. 1972. View Article : Google Scholar : PubMed/NCBI | |
Liu Q, Wu K, Qiu X, Yang Y, Lin X and Yu M: siRNA silencing of gene expression in trabecular meshwork: RhoA siRNA reduces IOP in mice. Curr Mol Med. 12:1015–1027. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tian B and Kaufman PL: Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculinA on outflow facility in monkeys. Exp Eye Res. 80:215–225. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yu M, Chen X, Wang N, Cai S, Li N, Qiu J, Brandt CR, Kaufman PL and Liu X: H-1152 effects on intraocular pressure and trabecular meshwork morphology of rat eyes. J Ocul Pharmacol Ther. 24:373–379. 2008. View Article : Google Scholar : PubMed/NCBI | |
Nishio M, Fukunaga T, Sugimoto M, Ikesugi K, Sumi K, Hidaka H and Uji Y: The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes. Curr Eye Res. 34:282–286. 2009. View Article : Google Scholar : PubMed/NCBI | |
Whitlock NA, Harrison B, Mixon T, Yu XQ, Wilson A, Gerhardt B, Eberhart DE, Abuin A and Rice DS: Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK. J Ocul Pharmacol Ther. 25:187–194. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lama PJ and Fechtner RD: Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 48:314–346. 2003. View Article : Google Scholar : PubMed/NCBI | |
Yoon PS and Singh K: Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol. 15:141–146. 2004. View Article : Google Scholar : PubMed/NCBI | |
Migdal C, Gregory W and Hitchings R: Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 101:1651–1656. 1994. View Article : Google Scholar : PubMed/NCBI | |
Khaw PT, Occleston NL, Schultz G, Grierson I, Sherwood MB and Larkin G: Activation and suppression of fibroblast function. Eye. 8:188–195. 1994. View Article : Google Scholar | |
Occleston NL, Daniels JT, Tarnuzzer RW, Sethi KK, Alexander RA, Bhattacharya SS, Schultz GS and Khaw PT: Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci. 38:1998–2007. 1997.PubMed/NCBI | |
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C and Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002. View Article : Google Scholar : PubMed/NCBI | |
Hinz B, Mastrangelo D, Iselin CE, Chaponnier C and Gabbiani G: Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol. 159:1009–1020. 2001. View Article : Google Scholar : PubMed/NCBI | |
Desmouliere A, Chaponnier C and Gabbiani G: Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 13:7–12. 2005. View Article : Google Scholar : PubMed/NCBI | |
Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, Schlunck G and Knaus P: p38 inhibitors prevent TGF-β-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci. 47:1500–1509. 2006. | |
Ehrlich HP and Rajaratnam JB: Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell. 22:407–417. 1990. View Article : Google Scholar : PubMed/NCBI | |
Desmouliere A, Redard M, Darby I and Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 146:56–66. 1995.PubMed/NCBI | |
Darby IA and Hewitson TD: Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol. 257:143–179. 2007. View Article : Google Scholar : PubMed/NCBI | |
Meyer-ter-Vehn T, Sieprath S, Katzenberger B, Gebhardt S, Grehn F and Schlunck G: Contractility as a prerequisite for TGF-β-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci. 47:4895–4904. 2006. | |
Miller MH, Grierson I, Unger WI and Hitchings RA: Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg. 20:350–357. 1989.PubMed/NCBI | |
Desmouliere A, Geinoz A, Gabbiani F and Gabbiani G: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 122:103–111. 1993. View Article : Google Scholar | |
Watsky MA: Lysophosphatidic acid, serum, and hyposmolarity activate Cl− currents in corneal keratocytes. Am J Physiol. 269:C1385–C1393. 1995.PubMed/NCBI | |
Cordeiro MF, Reichel MB, Gay JA, D’Esposita F, Alexander RA and Khaw PT: Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring. Invest Ophthalmol Vis Sci. 40:1975–1982. 1999.PubMed/NCBI | |
Cordeiro MF, Chang L, Lim KS, Daniels JT, Pleass RD, Siriwardena D and Khaw PT: Modulating conjunctival wound healing. Eye. 14:536–547. 2000. View Article : Google Scholar | |
Wong TT, Mead AL and Khaw PT: Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 44:1097–1103. 2003. View Article : Google Scholar | |
Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T and Narumiya S: An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med. 5:221–225. 1999. View Article : Google Scholar : PubMed/NCBI | |
Harvey SA, Anderson SC and SundarRaj N: Downstream effects of ROCK signaling in cultured human corneal stromal cells: microarray analysis of gene expression. Invest Ophthalmol Vis Sci. 45:2168–2176. 2004. View Article : Google Scholar : PubMed/NCBI | |
Yoshizaki H, Ohba Y, Parrini MC, Dulyaninova NG, Bresnick AR, Mochizuki N and Matsuda M: Cell type-specific regulation of RhoA activity during cytokinesis. J Biol Chem. 279:44756–44762. 2004. View Article : Google Scholar : PubMed/NCBI | |
Tomasek JJ, Vaughan MB, Kropp BP, Gabbiani G, Martin MD, Haaksma CJ and Hinz B: Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity. Wound Repair Regen. 14:313–320. 2006. View Article : Google Scholar : PubMed/NCBI | |
Parizi M, Howard EW and Tomasek JJ: Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res. 254:210–220. 2000. View Article : Google Scholar : PubMed/NCBI | |
Tangkijvanich P, Melton AC, Santiskulvong C and Yee HF Jr: Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration. J Biomed Sci. 10:352–358. 2003. View Article : Google Scholar : PubMed/NCBI | |
Honjo M, Tanihara H, Kameda T, Kawaji T, Yoshimura N and Araie M: Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 48:5549–5557. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lukas TJ, Miao H, Chen L, Riordan SM, Li W, Crabb AM, Wise A, Du P, Lin SM and Hernandez MR: Susceptibility to glaucoma: differential comparison of the astrocyte transcriptome from glaucomatous African American and Caucasian American donors. Genome Biol. 9:R1112008. View Article : Google Scholar : PubMed/NCBI | |
Hathaway DR, March KL, Lash JA, Adam LP and Wilensky RL: Vascular smooth muscle. A review of the molecular basis of contractility. Circulation. 83:382–390. 1991. View Article : Google Scholar : PubMed/NCBI | |
Savineau JP and Marthan R: Modulation of the calcium sensitivity of the smooth muscle contractile apparatus: molecular mechanisms, pharmacological and pathophysiological implications. Fundam Clin Pharmacol. 11:289–299. 1997. View Article : Google Scholar | |
Mita M, Yanagihara H, Hishinuma S, Saito M and Walsh MP: Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J. 364:431–440. 2002. View Article : Google Scholar : PubMed/NCBI | |
Sward K, Mita M, Wilson DP, Deng JT, Susnjar M and Walsh MP: The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep. 5:66–72. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K and Takeshita A: Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation. 101:1319–1323. 2000. View Article : Google Scholar : PubMed/NCBI | |
Sato M, Tani E, Fujikawa H and Kaibuchi K: Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 87:195–200. 2000. View Article : Google Scholar : PubMed/NCBI | |
Iizuka K, Shimizu Y, Tsukagoshi H, Yoshii A, Harada T, Dobashi K, Murozono T, Nakazawa T and Mori M: Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs. Eur J Pharmacol. 406:273–279. 2000. View Article : Google Scholar : PubMed/NCBI | |
Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW and Mills TM: Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med. 7:119–122. 2001. View Article : Google Scholar : PubMed/NCBI | |
Takahashi R, Nishimura J, Hirano K, Seki N, Naito S and Kanaide H: Ca2+ sensitization in contraction of human bladder smooth muscle. J Urol. 172:748–752. 2004. | |
Schubert R, Kalentchuk VU and Krien U: Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol. 283:H2288–H2295. 2002. View Article : Google Scholar : PubMed/NCBI | |
Cavarape A, Bauer J, Bartoli E, Endlich K and Parekh N: Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant. 18:1764–1769. 2003. View Article : Google Scholar : PubMed/NCBI | |
Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N and Endlich K: Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol. 14:37–45. 2003. View Article : Google Scholar : PubMed/NCBI | |
Randriamboavonjy V, Busse R and Fleming I: 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension. 41:801–806. 2003. View Article : Google Scholar : PubMed/NCBI | |
Watabe H, Abe S and Yoshitomi T: Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries. Jpn J Ophthalmol. 55:411–417. 2011. View Article : Google Scholar : PubMed/NCBI | |
Tokushige H: ROCK inhibitor and glaucoma. Bio Clinica. 17:1191–1194. 2002. | |
Sugiyama T, Shibata M, Kajiura S, Okuno T, Tonari M, Oku H and Ikeda T: Effects of fasudil, a Rho-associated protein kinase inhibitor, on optic nerve head blood flow in rabbits. Invest Ophthalmol Vis Sci. 52:64–69. 2011. View Article : Google Scholar : PubMed/NCBI | |
Okamura N, Saito M, Mori A, Sakamoto K, Kametaka S, Nakahara T and Ishii K: Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats. J Ocul Pharmacol Ther. 23:207–212. 2007. View Article : Google Scholar : PubMed/NCBI | |
Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P and Liao JK: Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 24:1842–1847. 2004. View Article : Google Scholar : PubMed/NCBI | |
Anderson DR: Introductory comments on blood flow auto-regulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol. 43:S5–S9. 1999. View Article : Google Scholar : PubMed/NCBI | |
Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ and Martin B: Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 43:S43–S50. 1999. View Article : Google Scholar : PubMed/NCBI | |
Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP and Stefansson E: The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 21:359–393. 2002. View Article : Google Scholar : PubMed/NCBI | |
Ben Simon GJ, Moroz I, Goldenfeld M and Melamed S: Scanning laser Doppler flowmetry of nonperfused regions of the optic nerve head in patients with glaucoma. Ophthalmic Surg Lasers Imaging. 34:245–250. 2003.PubMed/NCBI | |
Hu Y, Cui Q and Harvey AR: Interactive effects of C3, cyclic AMP and ciliaryneurotrophic factor on adult retinal ganglion cell survival and axonal regeneration. Mol Cell Neurosci. 34:88–98. 2007. View Article : Google Scholar : PubMed/NCBI | |
Kitaoka Y, Kitaoka Y, Kumai T, Lam TT, Kuribayashi K, Isenoumi K, Munemasa Y, Motoki M, Kobayashi S and Ueno S: Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina. Brain Res. 1018:111–118. 2004. View Article : Google Scholar : PubMed/NCBI | |
Bertrand J, Di Polo A and McKerracher L: Enhanced survival and regeneration of axotomized retinal neurons by repeated delivery of cell-permeable C3-like Rho antagonists. Neurobiol Dis. 25:65–72. 2007. View Article : Google Scholar : PubMed/NCBI | |
Sheikh AM, Nagai A, Ryu JK, McLarnon JG, Kim SU and Masuda J: Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia. 57:898–907. 2009. View Article : Google Scholar : PubMed/NCBI | |
Buchi ER: Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I Ganglion cell layer and inner nuclear layer. Exp Eye Res. 55:605–613. 1992. View Article : Google Scholar | |
Rosenbaum DM, Rosenbaum PS, Gupta A, Michaelson MD, Hall DH and Kessler JA: Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res. 37:3445–3451. 1997. View Article : Google Scholar : PubMed/NCBI | |
Hirooka K, Miyamoto O, Jinming P, Du Y, Itano T, Baba T, Tokuda M and Shiraga F: Neuroprotective effects of D-allose against retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 47:1653–1657. 2006. View Article : Google Scholar : PubMed/NCBI | |
Millán J and Ridley AJ: Free in PMC Rho GTPases and leucocyte-induced endothelial remodelling. Biochem J. 385:329–337. 2005.PubMed/NCBI | |
Wittchen ES, van Buul JD, Burridge K and Worthylake RA: Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration. Curr Opin Hematol. 12:14–21. 2005. View Article : Google Scholar : PubMed/NCBI | |
Song H and Gao D: Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats. Int J Mol Med. 28:193–198. 2011.PubMed/NCBI | |
Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Tojo SJ, Miyasaka M and Honda Y: Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. Invest Ophthalmol Vis Sci. 40:1183–1190. 1999.PubMed/NCBI | |
Hirata A, Inatani M, Inomata Y, Yonemura N, Kawaji T, Honjo M and Tanihara H: Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 246:51–59. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lingor P, Tönges L, Pieper N, Bermel C, Barski E, Planchamp V and Bähr M: ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain. 131:250–263. 2008.PubMed/NCBI | |
Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU and Henke-Fahle S: Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci. 50:452–461. 2009. View Article : Google Scholar : PubMed/NCBI | |
Fournier AE, GrandPre T, Gould G, Wang X and Strittmatter SM: Nogo and the Nogo-66 receptor. Prog Brain Res. 137:361–369. 2002. View Article : Google Scholar | |
Hunt D, Coffin RS and Anderson PN: The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. J Neurocytol. 31:93–120. 2002. View Article : Google Scholar | |
McKerracher L and Winton MJ: Nogo on the go. Neuron. 36:345–348. 2002. View Article : Google Scholar : PubMed/NCBI | |
Sandvig A, Berry M, Barrett LB, Butt A and Logan A: Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia. 46:225–251. 2004. View Article : Google Scholar : PubMed/NCBI | |
Fawcett JW: Overcoming inhibition in the damaged spinal cord. J Neurotrauma. 23:371–383. 2006. View Article : Google Scholar : PubMed/NCBI | |
Du J, Fu C and Sretavan DW: Eph/ephrin signaling as a potential therapeutic target after central nervous system injury. Curr Pharm Des. 13:2507–2518. 2007. View Article : Google Scholar : PubMed/NCBI | |
Fabes J, Anderson P, Brennan C and Bolsove S: Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord. Eur J Neurosci. 26:2496–2505. 2007. View Article : Google Scholar : PubMed/NCBI | |
Hou ST, Jiang SX and Smith RA: Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int Rev Cell Molec Biol. 267:125–181. 2008. View Article : Google Scholar : PubMed/NCBI | |
Berry M, Ahmed Z, Lorber B, Douglas M and Logan A: Regeneration of axons in the visual system. Restor Neurol Neurosci. 26:147–174. 2008.PubMed/NCBI | |
Bertrand J, Winton MJ, Rodriguez-Hernandez N, Campenot RB and McKerracher L: Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J Neurosci. 25:1113–1121. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sagawa H, Terasaki H, Nakamura M, Ichikawa M, Yata T, Tokita Y and Watanabe M: A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats. Exp Neurol. 205:230–240. 2007. View Article : Google Scholar : PubMed/NCBI | |
Monnier PP, Sierra A, Schwab JM, Henke-Fahle S and Mueller BK: The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci. 22:319–330. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lingor P, Teusch N, Schwarz K, Mueller R, Mack H, Bahr M and Mueller BK: Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J Neurochem. 103:181–189. 2007.PubMed/NCBI | |
Ahmed Z, Berry M and Logan A: ROCK inhibition promotes adult retinal ganglion cell neurite outgrowth only in the presence of growth promoting factors. Mol Cell Neurosci. 42:128–133. 2009. View Article : Google Scholar : PubMed/NCBI | |
Watanabe M: Regeneration of optic nerve fibers of adult mammals. Dev Growth Differ. 52:567–576. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tan H, Zhong Y, Shen X, Cheng Y, Jiao Q and Deng L: Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA/ROCK signaling pathway. Neuropharmacology. 63:1182–1190. 2012. View Article : Google Scholar : PubMed/NCBI |